Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-14 Sale |
2025-03-18 6:35 pm |
Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer |
79,146 | $12.9 | $1,021,211 | 174,306 (Direct) |
View |
| 2024-09-16 Purchase |
2024-09-18 6:02 pm |
Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
1,833,000 | $18 | $32,994,000 | 2,652,575 (Indirect) |
View |
| 2024-09-17 Purchase |
2024-09-17 6:16 pm |
Bicara Therapeutics Inc. | BCAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Members of 10% Group 10% Owner |
70,000 | $18 | $1,260,000 | 897,587 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-14 Exercise |
2025-03-18 6:35 pm |
N/A 2033-12-14 |
Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer |
78,966 | $0 | 174,306 (Direct) |
View |
| 2025-03-14 Exercise |
2025-03-18 6:35 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer |
79,146 | $5.45 | 174,306 (Direct) |
View |
| 2024-09-16 Conversion |
2024-09-18 6:02 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
52,477,415 | $0 | 2,652,575 (Indirect) |
View |
| 2024-09-16 Conversion |
2024-09-18 5:02 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | TPG GP A LLC BONDERMAN DAVID COULTER JAMES G WINKELRIED JON Former 10% Owner |
20,081,619 | $0 | 1,960,425 (Indirect) |
View |
| 2024-09-16 Conversion |
2024-09-18 11:54 am |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | FIL Ltd See Remark 1 |
1,013,853 | $0 | 1,013,853 (Indirect) |
View |
| 2024-09-16 Conversion |
2024-09-18 11:54 am |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | FMR LLC See Remark 1 |
1,115,333 | $0 | 1,115,333 (Indirect) |
View |
| 2024-09-17 Conversion |
2024-09-17 6:16 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Members of 10% Group 10% Owner |
16,809,237 | $0 | 897,587 (Indirect) |
View |
| 2024-09-12 Option Award |
2024-09-16 5:49 pm |
N/A 2034-09-12 |
Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
23,746 | $0 | 23,746 (Indirect) |
View |
| 2024-09-12 Option Award |
2024-09-16 4:42 pm |
N/A 2034-09-12 |
Bicara Therapeutics Inc. | BCAX | LONBERG NILS Director |
23,746 | $0 | 23,746 (Direct) |
View |
| 2024-09-12 Option Award |
2024-09-16 4:41 pm |
N/A 2034-09-12 |
Bicara Therapeutics Inc. | BCAX | Simson Jake Director |
23,746 | $0 | 23,746 (Direct) |
View |
| 2024-09-16 Conversion |
2024-09-16 4:39 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Biocon Ltd Biocon Pharma Inc. 10% Owner |
55,398,284 | $0 | 1,080,775 (Indirect) |
View |
| 2024-09-12 Option Award |
2024-09-16 4:38 pm |
N/A 2034-09-12 |
Bicara Therapeutics Inc. | BCAX | Haviland Kate Director |
23,746 | $0 | 23,746 (Direct) |
View |
| 2024-09-12 Option Award |
2024-09-16 4:35 pm |
N/A 2034-09-12 |
Bicara Therapeutics Inc. | BCAX | Robertson Scott M. Director |
23,746 | $0 | 23,746 (Direct) |
View |
| 2024-09-16 Conversion |
2024-09-16 4:35 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Mazumdar-Shaw Kiran Director 10% Owner |
63,155,572 | $0 | 456,482 (Indirect) |
View |
| 2024-09-12 Option Award |
2024-09-16 4:35 pm |
N/A 2034-09-12 |
Bicara Therapeutics Inc. | BCAX | Mazumdar-Shaw Kiran Director 10% Owner |
23,746 | $0 | 456,482 (Direct) |
View |
Ownership |
2024-09-12 9:27 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
0 | $0 | 5,122,993 (Indirect) |
View |
Ownership |
2024-09-12 9:20 pm |
N/A 2033-12-14 |
Bicara Therapeutics Inc. | BCAX | Meisner Lara Chief Legal Officer |
0 | $0 | 388,502 (Direct) |
View |
Ownership |
2024-09-12 9:19 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Hyep Ivan Chief Financial Officer |
0 | $0 | 1,103,415 (Direct) |
View |
Ownership |
2024-09-12 9:16 pm |
N/A 2034-08-06 |
Bicara Therapeutics Inc. | BCAX | POWELL MICHAEL Director |
0 | $0 | 59,501 (Direct) |
View |
Ownership |
2024-09-12 9:15 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Raben David Chief Medical Officer |
0 | $0 | 607,946 (Direct) |
View |
Ownership |
2024-09-12 9:11 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Mazumdar-Shaw Kiran Director 10% Owner |
0 | $0 | 6,306,188 (Direct) |
View |
Ownership |
2024-09-12 9:11 pm |
N/A 2034-08-06 |
Bicara Therapeutics Inc. | BCAX | Bowden Christopher Director |
0 | $0 | 59,501 (Direct) |
View |
Ownership |
2024-09-12 9:09 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Mazumdar Claire Chief Executive Officer |
0 | $0 | 2,674,577 (Direct) |
View |
Ownership |
2024-09-12 9:07 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Cohlhepp Ryan President and COO |
0 | $0 | 1,485,990 (Direct) |
View |
Ownership |
2024-09-12 9:07 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. *Possible Member of 10% Group 10% Owner |
0 | $0 | 1,725,174 (Indirect) |
View |
Ownership |
2024-09-12 9:03 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | LONBERG NILS Director |
0 | $0 | 68,275 (Direct) |
View |
Ownership |
2024-09-12 9:00 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Biocon Ltd Biocon Pharma Inc. 10% Owner |
0 | $0 | 5,523,897 (Indirect) |
View |
Ownership |
2024-09-12 9:00 pm |
N/A 2033-09-22 |
Bicara Therapeutics Inc. | BCAX | Robertson Scott M. Director |
0 | $0 | 59,501 (Direct) |
View |
Ownership |
2024-09-12 9:00 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | Haviland Kate Director |
0 | $0 | 59,500 (Direct) |
View |
Ownership |
2024-09-12 9:00 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | FMR LLC See Remark 1 10% Owner |
0 | $0 | 1,115,333 (Indirect) |
View |
Ownership |
2024-09-12 8:58 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | FIL Ltd See Remark 1 10% Owner |
0 | $0 | 1,013,853 (Indirect) |
View |
Ownership |
2024-09-12 8:48 pm |
N/A N/A |
Bicara Therapeutics Inc. | BCAX | TPG GP A LLC BONDERMAN DAVID COULTER JAMES G WINKELRIED JON 10% Owner |
0 | $0 | 1,960,425 (Indirect) |
View |